Company profile
TransCanna Holdings Inc.
OTC: TCNAF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ West Vancouver, BCReports USD
#747 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 29
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, Piotroski F · ↓ return on equity, market scale
Methodology →Revenue TTM
$3.1M
Rev growth YoY (TTM)
+89.8%
Net income (FY)
-$10.4M
Employees
19
as of 2026-08-29
Market cap
$12.0k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.2M4.0M CAD2021
Net income-$10.4M-13.1M CAD2021
Operating income-$7.5M-9.4M CAD2021
Total assets$20.0M25.6M CAD2021
Liabilities$17.5M22.4M CAD2021
Equity$2.5M3.3M CAD2021
Revenue trend
FY2017 – FY2021 · USD
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is TransCanna Holdings Inc.’s revenue?
TransCanna Holdings Inc. booked $3.2M in FY2021 revenue, contracting 38% year over year — slower than 79% of Healthcare companies we track, at a -327.4% net margin.
Peers · Healthcare
Nuo Therapeutics, Inc.48DADM Tronics Unlimited, Inc.——American Medical Technologies Inc.——Aptevo Therapeutics Inc.35DAvitar, Inc.——Aridis Pharmaceuticals, Inc.——Key facts
CEOJames Robert Blink
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersWest Vancouver, BC
ExchangeOTC: TCNAF
Employees19
IPO date2019-03-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.